Nomura Holdings Inc. Buys 5,684 Shares of Cardinal Health, Inc. (NYSE:CAH)

Nomura Holdings Inc. lifted its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 138.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,783 shares of the company's stock after purchasing an additional 5,684 shares during the period. Nomura Holdings Inc.'s holdings in Cardinal Health were worth $1,157,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of CAH. Rothschild Investment LLC boosted its position in Cardinal Health by 10.1% during the fourth quarter. Rothschild Investment LLC now owns 858 shares of the company's stock worth $101,000 after acquiring an additional 79 shares during the last quarter. Private Trust Co. NA lifted its stake in shares of Cardinal Health by 11.0% during the 4th quarter. Private Trust Co. NA now owns 930 shares of the company's stock worth $110,000 after purchasing an additional 92 shares during the period. Checchi Capital Advisers LLC increased its stake in shares of Cardinal Health by 2.7% during the 4th quarter. Checchi Capital Advisers LLC now owns 3,479 shares of the company's stock valued at $411,000 after acquiring an additional 93 shares during the last quarter. TIAA Trust National Association lifted its holdings in shares of Cardinal Health by 4.5% during the 4th quarter. TIAA Trust National Association now owns 2,183 shares of the company's stock worth $258,000 after acquiring an additional 94 shares during the period. Finally, MWA Asset Management boosted its position in shares of Cardinal Health by 2.9% in the fourth quarter. MWA Asset Management now owns 3,324 shares of the company's stock worth $393,000 after acquiring an additional 95 shares during the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Stock Down 0.6%

NYSE CAH traded down $0.90 during midday trading on Thursday, hitting $152.41. The company had a trading volume of 1,129,337 shares, compared to its average volume of 2,226,904. The firm has a fifty day simple moving average of $138.70 and a two-hundred day simple moving average of $128.54. The stock has a market cap of $36.38 billion, a price-to-earnings ratio of 28.43, a P/E/G ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $156.44.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The company reported $2.35 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.15 by $0.20. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. The company had revenue of $54.88 billion during the quarter, compared to analysts' expectations of $55.33 billion. During the same quarter in the prior year, the company posted $2.08 EPS. The business's revenue was up .0% on a year-over-year basis. As a group, equities analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be given a $0.5107 dividend. This is an increase from Cardinal Health's previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $2.04 annualized dividend and a yield of 1.34%. Cardinal Health's payout ratio is presently 31.83%.

Analyst Ratings Changes

CAH has been the subject of a number of research reports. Wells Fargo & Company boosted their target price on Cardinal Health from $135.00 to $136.00 and gave the stock an "equal weight" rating in a report on Tuesday, February 4th. Bank of America increased their price objective on shares of Cardinal Health from $150.00 to $155.00 and gave the stock a "buy" rating in a research report on Friday, April 11th. Mizuho raised their target price on shares of Cardinal Health from $142.00 to $150.00 and gave the company an "outperform" rating in a research note on Monday, March 31st. Morgan Stanley upped their price target on shares of Cardinal Health from $142.00 to $166.00 and gave the stock an "overweight" rating in a research report on Monday, May 5th. Finally, Citigroup reissued a "neutral" rating on shares of Cardinal Health in a research report on Thursday, May 1st. Four research analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $146.43.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.